have voiced over the years my concern for their ability to scale up to meet a contractual demand AND be reproducible with regard to the quality of the product.   When I choose to get involved with something like KBLB back in 2016, I do so because they have a 'window of opportunity' to 'make it'...  But in this world, I am also willing to admit, those windows of opportunity better be taken advantage of, or they close and the reason for buying in, decreases.  And I have seen some companies essentially do nothing from a share price even tho the idea was great because the competition passed them by and neutralized their advantages.

   I am seeing that now with the synthetics.   WIth the discussion that their cost to produce has dropped, and their ability to 'scale up' and because its a controlled manufacturing process, be reliable in the quality of their product, I no longer see KBLB having the tactical advantage that I once did in terms of competing for contracts.

 

  So sold my nearly 90000 shares this morn....   will keep an eye on it, and its possible they get to my target of a qtr/sh...   but the venture capitalists are speaking volumes, cause they are putting their money into the synthetics....   thats also a tell that the competition has 'caught up' enough to hurt KBLB prospects...

 

  Ok, well good luck to all...  going to roll this money (and its not a lot) into another one that is on the verge of making a move (bio company)...  and will keep an eye on this one out of curiosity and just in case, something finally breaks their way..